Company intelligence

BlossomHill

BiotechActive
We're still building this profile — here is what Pulse has covered.

Latest Pulse

  1. Biotech IPO Window Closes Its Strongest Week Since SpringBlossomHill and Latigo Biotherapeutics both closed upsized IPOs by August 10, capping a four-deal stretch that also included Braveheart Bio and Attovia Therapeutics pricing above or near the top of their ranges.→
  2. Biotech IPOs Are Pricing Above Range AgainBlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.→

Coverage Timeline

newest first
  1. IPOBiotech IPO Window Closes Its Strongest Week Since Spring→
  2. IPOBiotech IPOs Are Pricing Above Range Again→

All Coverage

IPO

Biotech IPO Window Closes Its Strongest Week Since Spring

IPO

Biotech IPOs Are Pricing Above Range Again

Related Companies

Same sector
Attovia TherapeuticsApnimedBraveheart BioLatigo BiotherapeuticsScribe Therapeutics